Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Tandem Diabetes Care is 40 — signals are mixed heading into the print. Underlying trend: 6 tracked signals showing mixed direction over the last 3 months.
Tandem Diabetes Care (TNDM) is trading at $22.81, up 61.7% over the last 3 months (from $14.11 three months ago).
Trends across the last 3 months — the run-up to Tandem Diabetes Care’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 83 | ↓ -7.8% |
| LinkedIn headcount | 2,208 | → +1.4% |
| Web traffic | 433,787 | ↑ +13.0% |
| Employee business outlook | 29% Negative | → flat |
| Instagram followers | 56,201 | → +3.0% |
| X followers | 11,899 | → -0.1% |
Full daily-resolution trend charts on every signal are on the TNDM ticker page.
AltIndex stock alerts fire when alt-data on TNDM breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Tandem Diabetes Care — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in